StockData
Mesoblast Ltd logo

Mesoblast Ltd (MESO) stock

MESONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30Also trades as MEOBF
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Aug 27, 2026Score 6/30
$11.91−0.54 (-4.34%)

Close on Nov 17, 2026Market cap $1.54BP/E –Yield –

Mesoblast market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Mesoblast's market cap was $1.77B on Nov 11, 2026, against $2.08B a year earlier. Over the last 5 years it ranged from $136.88M to $2.18B, with a median of $578.62M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.77B-18.9%
2025Dec 31, 2025$2.18B+11.5%
2024Dec 31, 2024$1.95B+1041.8%
2023Dec 29, 2023$171.10M-57.7%
2022Dec 30, 2022$404.42M-32.2%
2021Dec 31, 2021$596.67M-36.1%
2020Dec 31, 2020$933.32M+27.3%
2019Dec 31, 2019$733.09M+87.5%
2018Dec 31, 2018$391.05M-16.1%
2017Dec 29, 2017$466.08M+19.6%
2016Dec 30, 2016$389.70M–

More Mesoblast figures

See a number that looks wrong?